Previous 10 | Next 10 |
Amgen (AMGN), Genmab A/S (GMAB), Seattle Genetics (SGEN), and Alexion Pharmaceuticals (ALXN) are leading biotech companies engaged in developing cancer drugs. As the number of cancer patients rises with each passing day, these stocks should continue to move higher. Biotech stocks are amon...
Agenus's balstilimab and zalifrelimab nears FDA submission for cervical cancer. Seattle Genetics presented tisotumab vedotin cervical cancer data at ESMO. They may compete in the marketplace despite differing mechanisms of action. For further details see: Agenus Vs. Seat...
Moderna (MRNA) is one of the leading biotech manufacturers in the race to develop a coronavirus vaccine. The stock seems overvalued by traditional measures, but the company’s unique approach to developing the vaccine could move the stock in either direction. Moderna, Inc. (...
InSysBio collaborates with Genmab ([[GMAB]] -8.8%) for GEN1042, a bispecific agonistic antibody for solid tumors.The key aim of this collaboration is to develop a quantitative system pharmacology ((QSP)) model that allows exploration of the relationships between dose, schedule, and tumor...
AC Immune SA (ACIU) -43% as semorinemab flunks Alzheimer's study.Wave Life Sciences (WVE) -31% after pricing equity offering.Aurora Cannabis (ACB) -17% on soft revenue outlook.NanoVibronix (NAOV) -17% after increasing the size of the previous publi...
Genmab (GMAB) down 12% premarket in reaction to the announcement that it was locked in a legal battle with its partner Johnson & Johnson (JNJ) over royalty payments for its key cancer drug, source Reuters.Yesterday, GMAB commenced binding arbitration of two matters under license...
Healthcare players such as Regeneron Pharmaceuticals (REGN), Genmab (GMAB), Horizon Therapeutics (HZNP), and Bio-Rad Laboratories (BIO) demonstrated high-profit margins and are expected to witness a surge in their earnings, revenue, and profit margins with the advent of a definitive vaccine for...
This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsen’s 13F stock portfolio on a quarterly basis. It is based on Viking Global’s regulatory 13F Form filed on 08/7/2020. Please visit our Tracking Ole Andreas Halvorsen&...
The FDA approves the use of Johnson & Johnson (NYSE: JNJ ) unit Janssen Biotech's Darzalex (daratumumab) to treat adults with relapsed/refractory multiple myeloma who have received one to three previous lines of therapy. More news on: Johnson & Johnson, Genmab A/S, Healthcare s...
Genmab A/S (NASDAQ: GMAB ) will receive a $30M payment from licensee Novartis (NYSE: NVS ) to account for lost royalties from blood cancer med Arzerra (ofatumumab). More news on: Genmab A/S, Novartis AG, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-08-01 01:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 78.0% to $0.58749 on volume of 130,454,575 shares Ocean Power Technologies Inc. (OPTT) rose 29.6% to $0.2073 on volume of 51,927,154 shares Cosmos Health Inc. (COSM) rose 64.9% to $1.12 on volume of...
Company Announcement Positive CHMP opinion based on results from the Phase 1/2 EPCORE ® NHL-1 study FL is the second most common type of NHL and accounts for approximately 20-30 percent of all global cases If approved, epcoritamab (TEPKINLY ® ...